Gubra A/S Logo

Gubra A/S

Preclinical CRO and peptide drug developer for metabolic and fibrotic diseases.

GUBRA | CO

Overview

Corporate Details

ISIN(s):
DK0062266474
LEI:
254900T17RRFZONO6W53
Country:
Denmark
Address:
Hørsholm Kongevej 11 B, 2970 Hørsholm
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Gubra is a biotechnology company and preclinical Contract Research Organization (CRO) founded in 2008. The company operates a dual business model, providing specialized preclinical research services while simultaneously developing its own pipeline of peptide-based therapeutics. Gubra's core expertise lies in metabolic diseases (such as obesity, diabetes, and MASH) and fibrotic diseases. Its CRO services support pharmaceutical and biotech clients with advanced studies, including in vivo pharmacology and peptide chemistry. The drug discovery division focuses on advancing a proprietary portfolio of novel drug candidates, with research and development efforts also extending into inflammatory, CNS, respiratory, and women's health conditions. This integrated approach combines stable service revenue with the long-term potential of therapeutic innovation.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Gubra A/S and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Gubra A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Gubra A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Aran Research & Development (1982) Ltd. Logo
End-to-end product & machine development for plastics, medical, and industrial markets.
Israel ARAN
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
AroCell AB Logo Sweden AROC
Arterra Bioscience Logo
Develops sustainable active ingredients from plant cell cultures for diverse industries.
Italy ABS
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP
Ascelia Pharma Logo
Developing novel drugs for rare cancer conditions, including an oral MRI contrast agent.
Sweden ACE
AVACTA GROUP PLC Logo
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
United Kingdom AVCT
BenevolentAI Logo
AI-powered platform that analyzes biomedical data to accelerate drug discovery.
United Kingdom BAI
BerGenBio Logo
Develops first-in-class AXL inhibitors for cancer and severe respiratory infections.
Norway BGBIO
BioArctic Logo
Biopharma developing treatments & diagnostics for neurodegenerative diseases like Alzheimer's.
Sweden BIOA

Talk to a Data Expert

Have a question? We'll get back to you promptly.